Mirae Asset Global Investments Co., Ltd. Sanofi Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $24 Billion
  • Q4 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sanofi stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,773 shares of SNY stock, worth $587,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,773
Previous 11,721 8.09%
Holding current value
$587,774
Previous $675,000 23.11%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025
SELL
$45.89 - $57.31 $43,503 - $54,329
-948 Reduced 8.09%
10,773 $519,000
Q3 2024

Oct 23, 2024
BUY
$48.54 - $58.53 $101,934 - $122,913
2,100 Added 21.83%
11,721 $675,000
Q2 2024

Jul 30, 2024
SELL
$45.39 - $50.36 $1.82 Million - $2.01 Million
-39,997 Reduced 80.61%
9,621 $466,000
Q1 2024

May 01, 2024
BUY
$45.75 - $52.48 $149,511 - $171,504
3,268 Added 7.05%
49,618 $2.41 Million
Q4 2023

Jan 24, 2024
BUY
$43.13 - $54.79 $106,272 - $135,002
2,464 Added 5.61%
46,350 $2.3 Million
Q3 2023

Oct 26, 2023
SELL
$50.95 - $55.2 $731,642 - $792,672
-14,360 Reduced 24.65%
43,886 $2.35 Million
Q2 2023

Aug 10, 2023
BUY
$50.45 - $57.18 $634,862 - $719,553
12,584 Added 27.56%
58,246 $3.14 Million
Q1 2023

May 04, 2023
BUY
$45.86 - $54.45 $96,948 - $115,107
2,114 Added 4.85%
45,662 $2.48 Million
Q4 2022

Feb 09, 2023
BUY
$38.86 - $48.55 $124,235 - $155,214
3,197 Added 7.92%
43,548 $2.11 Million
Q3 2022

Nov 10, 2022
BUY
$37.22 - $100.5 $1.5 Million - $4.06 Million
40,351 New
40,351 $1.53 Million
Q2 2022

Jul 26, 2022
SELL
$48.99 - $57.46 $649,852 - $762,206
-13,265 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$48.48 - $53.65 $274,784 - $304,088
-5,668 Reduced 29.94%
13,265 $681,000
Q4 2021

Feb 08, 2022
BUY
$47.07 - $52.35 $328,972 - $365,874
6,989 Added 58.51%
18,933 $949,000
Q3 2021

Nov 15, 2021
BUY
$47.89 - $53.12 $82,897 - $91,950
1,731 Added 16.95%
11,944 $576,000
Q2 2021

Aug 11, 2021
BUY
$49.36 - $54.25 $4,195 - $4,611
85 Added 0.84%
10,213 $538,000
Q1 2021

May 13, 2021
SELL
$45.46 - $50.51 $26,366 - $29,295
-580 Reduced 5.42%
10,128 $501,000
Q4 2020

Feb 10, 2021
SELL
$45.3 - $51.62 $2.44 Million - $2.78 Million
-53,848 Reduced 83.41%
10,708 $520,000
Q3 2020

Nov 12, 2020
BUY
$49.47 - $53.77 $39,130 - $42,532
791 Added 1.24%
64,556 $3.24 Million
Q2 2020

Aug 11, 2020
SELL
$42.91 - $52.5 $120,920 - $147,945
-2,818 Reduced 4.23%
63,765 $3.26 Million
Q1 2020

May 12, 2020
BUY
$38.02 - $51.66 $228,690 - $310,734
6,015 Added 9.93%
66,583 $2.91 Million
Q4 2019

Feb 12, 2020
BUY
$44.25 - $50.86 $73,233 - $84,173
1,655 Added 2.81%
60,568 $3.04 Million
Q3 2019

Nov 12, 2019
SELL
$40.34 - $46.64 $548,866 - $634,583
-13,606 Reduced 18.76%
58,913 $2.73 Million
Q2 2019

Aug 13, 2019
BUY
$40.43 - $44.3 $2.93 Million - $3.21 Million
72,519 New
72,519 $3.14 Million
Q1 2019

May 13, 2019
SELL
$40.83 - $45.43 $2.57 Million - $2.86 Million
-62,863 Closed
0 $0
Q4 2018

Feb 11, 2019
BUY
$41.48 - $45.59 $1.88 Million - $2.07 Million
45,315 Added 258.23%
62,863 $2.73 Million
Q3 2018

Nov 13, 2018
SELL
$40.0 - $44.84 $90,840 - $101,831
-2,271 Reduced 11.46%
17,548 $784,000
Q2 2018

Aug 14, 2018
SELL
$37.63 - $41.22 $269,656 - $295,382
-7,166 Reduced 26.56%
19,819 $793,000
Q1 2018

May 10, 2018
SELL
$38.98 - $45.76 $597,017 - $700,860
-15,316 Reduced 36.21%
26,985 $1.08 Million
Q4 2017

Feb 12, 2018
BUY
$42.86 - $50.61 $312,835 - $369,402
7,299 Added 20.85%
42,301 $1.82 Million
Q3 2017

Nov 08, 2017
SELL
$47.04 - $50.34 $33,257 - $35,590
-707 Reduced 1.98%
35,002 $1.74 Million
Q2 2017

Aug 14, 2017
BUY
N/A
35,709
35,709 $1.71 Million

Others Institutions Holding SNY

# of Institutions
805
Shares Held
272M
Call Options Held
2M
Put Options Held
1.9M
View Full List

About Sanofi

SNY Quotes by TradingView
  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $137B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email